Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01437228
Other study ID # gungorduk13
Secondary ID
Status Completed
Phase Phase 4
First received September 6, 2011
Last updated November 16, 2011
Start date October 2010
Est. completion date April 2011

Study information

Verified date November 2011
Source Erzincan Military Hospital
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug AdministrationTurkey: Ethics Committee
Study type Interventional

Clinical Trial Summary

Cesarean delivery rates are increasing in Turkey and a major component of this increase is cesarean on demand. Although data on the rate of cesarean delivery in Turkey is limited, a national study reported a rate of 23.8%. Infectious morbidity, consisting primarily of endomyometritis and wound infection, remains a leading cause of postoperative complications. Estimates of postcesarean infection rates range from 7% to 20%, depending on demographic and obstetric variables. Infection following cesarean delivery results in not only increased hospital stay but also increases the cost of care. Strategies to minimize postoperative infectious and other morbidities have included modifications of surgical technique, changing of gloves, methods of placental delivery, cervical dilatation during cesarean delivery, and altering the uterine position during repair of the uterine incision. Despite these interventions, endometritis is still major problem after cesarean delivery.

Endometritis appears to result from ascending vaginal flora bacteria, with anaerobes playing an important role. The microbes endogenous to the vagina change throughout the course of pregnancy and parturition. Larsen and Galask noted that anaerobic species located in the vagina increase dramatically by the third postpartum day. In many cases, the surgeon's hand, reaching below the infant's head or presenting part, is in direct contact with the vagina. Vaginal bacterial flora have been cultured from the delivering surgeon's glove in 79% (95% confidence interval [CI] 58%, 100%) of cesareans that follow labor. In these cases, vaginal flora are delivered directly to the uterus, abdominal cavity, and the abdominal incision. Vaginal preparation has been shown to decrease the quantitative load of vaginal microorganisms as well as to remove certain species of bacteria.


Recruitment information / eligibility

Status Completed
Enrollment 668
Est. completion date April 2011
Est. primary completion date March 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Women older than 38 weeks estimated gestational age and required cesarean section.

Exclusion Criteria:

- Highly emergent cesarean

- Allergy to povidone iodine

- Chorioamnionitis on admission

- Fever on admission

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Drug:
povidone- iodine solution.
%10 Polivinilpirolidon iyot (Polividon- iyot
placebo
NO INTERVENTION

Locations

Country Name City State
Turkey Sisli Etfal Hospital Istanbul Sisli

Sponsors (1)

Lead Sponsor Collaborator
Erzincan Military Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary rate of postpartum endometritis Endometritis was defined here as body temperature greater than 38.5C with concomitant foul-smelling discharge or abnormally tender uterus on bimanual examination 6 weeks Yes
Secondary morbidity Infectious morbidity was documented using established clinical criteria. Febrile morbidity was defined as a persistent fever of at least 38C for at least 24 hours after surgery and not associated with lower abdominal or pelvic tenderness and no signs of infection elsewhere. two days Yes
See also
  Status Clinical Trial Phase
Terminated NCT05603624 - Effect of Sterile Versus Clean Gloves Intrapartum and Postpartum Infections at Term N/A
Completed NCT04385680 - Chlorhexidine Vaginal Preparation for Reduction of Post-cesarean Endometritis and Sepsis Phase 1/Phase 2
Terminated NCT03478163 - Antibiotics During Intrauterine Balloon Tamponade Placement Phase 4
Not yet recruiting NCT03840889 - Secondary Postpartum Hemorrhage
Completed NCT03248297 - Antibiotic Prophlaxis for High-risk Laboring Women in Low Income Countries Phase 4
Completed NCT05118984 - Efficacy of Azithromycin in MSAF Cases to Improve Maternal and Neonatal Outcomes Phase 4